FMC Files First Global Regulatory Submission With EPA for Rimisoxafen
FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.
FMC - FMC Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$15.75
DETAILS
HIGH:
$20.00
LOW:
$14.00
MEDIAN:
$14.75
CONSENSUS:
$15.75
UPSIDE:
44.63%
Stock News
FMC Corporation Files First Global Regulatory Submission for Rimisoxafen with United States Environmental Protection Agency
The submission marks an important milestone in FMC's efforts to advance next-generation weed control technologies as resistance pressure intensifies in key row crop markets. PHILADELPHIA, July 8, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has submitted the regulatory dossier for rimisoxafen to the United States (U.S.) Environmental Protection Agency (EPA), the first regulatory submission globally for this groundbreaking herbicide active ingredient.
FMC Lands $400M Minority Investment From Tessenderlo Group
FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.
FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group
FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group PR Newswire
FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group
Tessenderlo Group's investment reflects its strategy of making cornerstone minority investments in high-quality companies Investment enables FMC to achieve approximately $1 billion debt paydown target FMC concludes strategic options review FMC maintains focus on delivering on its operational and strategic plan PHILADELPHIA and BRUSSELS, June 30, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, and Tessenderlo Group (XBRU: TESB), a Belgian-based industrial group, today announced that they have entered into a definitive agreement under which Tessenderlo Group will make a strategic minority equity investment in FMC Corporation of approximately $400 million USD at a price of $13.30 per share. Upon completion of the transaction, Tessenderlo Group will own approximately 20.0% of the outstanding shares of FMC common stock.
FMC to Sell Newark Property for $114M, Use Proceeds to Cut Debt
FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.
FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property
Company will continue to operate its global R&D headquarters at the Stine Research Center PHILADELPHIA, June 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that it has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement.
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call
PHILADELPHIA, June 22, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m.
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology
FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.
FMC Corporation (FMC) Presents at 3rd Annual Materials of the Future Conference Transcript
FMC Corporation (FMC) Presents at 3rd Annual Materials of the Future Conference Transcript
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) and Corteva, Inc. (NYSE: CTVA), two leading global agricultural science and innovation companies, today announced a co-exclusive strategic supply and license agreement that will expand access to FMC's rimisoxafen technology across North and South America corn and soybean markets, adding an important new tool to each company's respective herbicide portfolio. This collaboration will enable more growers across the Americas to control herbicide-resistant weeds, including Amaranthus species – the number one weed resistance challenge globally in soybeans and critical in cross-crop pressure in corn – with this groundbreaking dual mode of action herbicide technology.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Wolfe Research 3rd Annual Materials of the Future Conference
PHILADELPHIA, June 10, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the Wolfe Research 3rd Annual Materials of the Future conference on June 17, 2026, at 9:15 a.m. Eastern Time.
FMC Corporation (FMC) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
FMC Corporation (FMC) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
FMC (FMC) Down 11.8% Since Last Earnings Report: Can It Rebound?
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
FMC Corp. Just Agreed to Sell Its India Commercial Business. Here's What That Means for the Stock in 2026.
FMC sold an asset to pay down debt, but the company is by no means out of the woods.
FMC Corporation CFO Andrew Sandifer to speak at 16th Annual Wells Fargo Industrials & Materials Conference
PHILADELPHIA, May 26, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the 16th Annual Wells Fargo Industrials & Materials Conference on June 9, 2026, at 2:15 p.m. Central Time.
Why FMC Stock Was Sinking This Week
The company is issuing $1.2 billion in secured convertible senior notes. Much of the proceeds will be directed toward paying down other notes maturing in October.
If You'd Invested in FMC Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: It's Not Pretty)
The company's stock valuation looks attractive at recent levels. But revenue has been falling and the company is exploring some extreme options.
FMC Corporation (FMC) Presents at 21st Annual Global Farm to Market Conference Transcript
FMC Corporation (FMC) Presents at 21st Annual Global Farm to Market Conference Transcript
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at BMO Global Farm to Market Chemicals Conference
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the BMO Global Farm to Market Chemicals Conference on May 14, 2026, at 1:15 p.m. Eastern Time.
Price Targets
FMC price target lowered to $14 from $15 at BMO Capital
$14.00
(was $11.35)
BMO Capital
FMC price target raised to $17 from $14 at Wells Fargo
$17.00
(was $17.35)
Wells Fargo
FMC price target lowered to $20 from $21 at Mizuho
$20.00
(was $14.34)
Edlain Rodriguez
·
Mizuho Securities
FMC price target lowered to $15.50 from $17 at Morgan Stanley
$15.50
(was $14.43)
Morgan Stanley
FMC price target lowered to $14 from $16 at RBC Capital
$14.00
(was $14.29)
RBC Capital
FMC price target lowered to $14 from $15 at UBS
$14.00
(was $14.02)
UBS
FMC price target lowered to $14 from $16 at Wells Fargo
$14.00
(was $13.67)
Michael Sison
·
Wells Fargo
FMC price target lowered to $16 from $17 at RBC Capital
$16.00
(was $15.77)
Arun Viswanathan
·
RBC Capital
FMC price target lowered to $21 from $24 at Mizuho
$21.00
(was $15.48)
Mizuho Securities
FMC price target lowered to $15 from $17 at UBS
$15.00
(was $15.39)
UBS
FMC price target lowered to $24 from $30 at Mizuho
$24.00
(was $13.89)
Mizuho Securities
FMC downgraded to Underweight from Equal Weight at Barclays
$13.00
(was $13.10)
Benjamin Theurer
·
Barclays
FMC price target lowered to $17 from $38 at Morgan Stanley
$17.00
(was $14.33)
Morgan Stanley
FMC price target lowered to $17 from $33 at RBC Capital
$17.00
(was $15.53)
Arun Viswanathan
·
RBC Capital
FMC price target lowered to $17 from $36 at UBS
$17.00
(was $15.53)
Joshua Spector
·
UBS
FMC downgraded to Equal Weight from Overweight at Wells Fargo
$16.00
(was $15.53)
Wells Fargo
FMC downgraded to Equal Weight from Overweight at Barclays
$22.00
(was $29.04)
Barclays
FMC price target lowered to $43 from $50 at Goldman Sachs
$43.00
(was $29.95)
Goldman Sachs
FMC price target lowered to $41 from $50 at Wells Fargo
$41.00
(was $30.09)
Richard Garchitorena
·
Wells Fargo
FMC price target lowered to $39 from $49 at Mizuho
$39.00
(was $30.34)
Mizuho Securities